Order Article Reprints

Yoo H, Choi S-K, Lee J, Park SH, Park YN, Hwang S-Y, Shin J-H, Na Y, Kwon Y, Lee HJ, et al. Drug-Like Small Molecule HSP27 Functional Inhibitor Sensitizes Lung Cancer Cells to Gefitinib or Cisplatin by Inducing Altered Cross-Linked Hsp27 Dimers. Pharmaceutics. 2021; 13(5):630. https://doi.org/10.3390/pharmaceutics13050630

Yoo, Hawon, Seul-Ki Choi, Jaeok Lee, So Hyeon Park, You Na Park, Soo-Yeon Hwang, Jae-Ho Shin, Younghwa Na, Youngjoo Kwon, Hwa Jeong Lee, and et al. 2021. "Drug-Like Small Molecule HSP27 Functional Inhibitor Sensitizes Lung Cancer Cells to Gefitinib or Cisplatin by Inducing Altered Cross-Linked Hsp27 Dimers" Pharmaceutics 13, no. 5: 630. https://doi.org/10.3390/pharmaceutics13050630

Yoo, H., Choi, S.-K., Lee, J., Park, S. H., Park, Y. N., Hwang, S.-Y., Shin, J.-H., Na, Y., Kwon, Y., Lee, H. J., & Lee, Y.-S. (2021). Drug-Like Small Molecule HSP27 Functional Inhibitor Sensitizes Lung Cancer Cells to Gefitinib or Cisplatin by Inducing Altered Cross-Linked Hsp27 Dimers. Pharmaceutics, 13(5), 630. https://doi.org/10.3390/pharmaceutics13050630